to determine if a lower interferon dose would induce a comparable antileukemic effect with less toxicity , a-2b ifn was administered at 2 x 10 ( 5 ) u/m2 subcutaneously three times per week to 17 patients with progressive hcl .
C0021747
interferon
C0023443
hcl